CYTOKINETICS INC — Director's Dealing 2023

Aug 11, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2022-12-21

Reporting Person: Blum Robert I (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-12-21	Common Stock	M	10000	$9.65	Acquired	416412	Direct
2022-12-21	Common Stock	S	10000	$43.924	Disposed	406412	Direct
2023-08-11	Common Stock	M	11708	$9.65	Acquired	453125	Direct
2023-08-11	Common Stock	S	11708	$32.3671	Disposed	441417	Direct
2023-08-11	Common Stock	M	792	$7.96	Acquired	442209	Direct
2023-08-11	Common Stock	S	792	$32.3671	Disposed	441417	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-12-21	Non-Qualified Stock Option (Right to Buy)	$9.65	M	10000	Disposed	2024-02-24	Common Stock (10000)	Direct
2023-08-11	Incentive Stock Option (Right to Buy)	$9.65	M	11708	Disposed	2024-02-24	Common Stock (11708)	Direct
2023-08-11	Incentive Stock Option (Right to Buy)	$7.96	M	792	Disposed	2025-02-26	Common Stock (792)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2083	Indirect
Common Stock	2083	Indirect

Footnotes

F1: Shares held by The Bridget Blum 2003 Irrevocable Trust.

F2: Shares held by The Brittany Blum 2003 Irrevocable Trust.

F3: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

F4: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 27, 2022.